Home
Dashboard
Curated content

Startups & Scaleups
New startups
Job board
Corporates
Investors
Funding rounds
Exits

Accelerators
Workspaces
Universities
More organizations

Matching tool
Investment heatmap
Themes

News

Contact
FAQ
Privacy

Companies
Angion Biomedica
Team
Team

Angion Biomedica

Clinical stage organ restoration biopharmaceutical company focused on renal disease. Learn more

Launch date

1998

Employees

Market cap

AUD465m

Enterprise valuation

AUD421m (Public information from Jun 2023)

Share price

$1 ANGN

Hempstead New York (HQ)

http://angion.com

https://twitter.com/angionbiomedica https://www.linkedin.com/company/angion/

B2B
health
biotechnology
pharmaceutical

hard tech
biotechnology
biotech and pharma
surgery

Authorizing premium user...